Literature DB >> 2819387

The neurogenic overactive bladder. Classification based on urodynamics.

M Fall1, B L Ohlsson, C A Carlsson.   

Abstract

The aetiology and pathogenesis of bladder overactivity are very variable and the classification is rather crude. By careful interpretation of clinical findings and urodynamic assessments, refinement of the diagnosis is possible. From a therapeutic and prognostic stand-point, it is of interest to distinguish between "idiopathic detrusor instability" and the "uninhibited overactive bladder". Based on neurological investigation and cystometric recordings, including the ice water test, characteristics of the 2 entities are described.

Entities:  

Mesh:

Year:  1989        PMID: 2819387     DOI: 10.1111/j.1464-410x.1989.tb06045.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  5 in total

Review 1.  Lower urinary tract disease: what are we trying to treat and in whom?

Authors:  Jeremy P W Heaton
Journal:  Br J Pharmacol       Date:  2006-02       Impact factor: 8.739

2.  Is submucosal bladder pressure monitoring feasible?

Authors:  Anisha S Basu; Steve Majerus; Elizabeth Ferry; Iryna Makovey; Hui Zhu; Margot S Damaser
Journal:  Proc Inst Mech Eng H       Date:  2018-01-29       Impact factor: 1.617

3.  Characteristics of persons with overactive bladder of presumed neurologic origin: results from the Boston Area Community Health (BACH) survey.

Authors:  Susan A Hall; Teresa M Curto; Ahunna Onyenwenyi; Gary E Lemack; Sharon L Tennstedt; Carol L Link; John B McKinlay
Journal:  Neurourol Urodyn       Date:  2012-06-06       Impact factor: 2.696

4.  Positive ice-water test: a predictor of neurological disease?

Authors:  M Fall; G Geirsson
Journal:  World J Urol       Date:  1996       Impact factor: 4.226

5.  The effect of levcromakalim (BRL 38227) on bladder function in patients with high spinal cord lesions.

Authors:  K Komersova; J W Rogerson; E L Conway; T C Lim; D J Brown; H Krum; G P Jackman; R Murdoch; W J Louis
Journal:  Br J Clin Pharmacol       Date:  1995-02       Impact factor: 4.335

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.